XWAR
IPE
Market cap59mUSD
Jul 10, Last price
7.40PLN
1D
-1.07%
1Q
26.28%
Jan 2017
285.42%
IPO
-7.50%
Name
Ipopema Securities SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2005 in Warsaw, Poland, IPOPEMA Securities S.A. is a financial services firm delivering a comprehensive range of brokerage, equity research, and investment banking solutions. The company's operations are organized into distinct divisions. Its Investment Fund and Portfolio Management segment focuses on the creation and oversight of various investment funds, including both open-end and closed-end structures, alongside managing portfolios of financial instruments for clients. The Brokerage and Investment Banking division undertakes securities brokerage, the distribution of investment products, and provides investment advisory services to individual investors. This extensive segment also covers a full spectrum of investment banking activities, such as the preparation and execution of equity capital market transactions, public securities offerings, mergers and acquisitions (M&A), and management buy-outs. Additionally, it offers expert advice on corporate financial restructuring, assists in securing funding for infrastructure projects, and guides clients through private market financing. IPOPEMA Securities S.A. further supports companies listed on the Warsaw Stock Exchange with share repurchase initiatives, including tender offers and buyback programs. Through its Advisory Service segment, the company delivers specialized expertise in business and management consulting, complemented by IT-related services such as computer facilities management, general IT advisory, and various software solutions. Beyond these primary financial offerings, IPOPEMA Securities S.A. also provides intermediation services and engages in the wholesale distribution of computer hardware, peripherals, equipment, and software.
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||